Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Fennec Pharmaceuticals Inc have a median target of 14.50, with a high estimate of 22.00 and a low estimate of 13.00. The median estimate represents a 174.10% increase from the last price of 5.29.
High | 315.9% | 22.00 |
Med | 174.1% | 14.50 |
Low | 145.7% | 13.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 04, 2024.
Average growth rate | +11.90% |
Average growth rate | -1.98% |
More ▼
Revenue history & estimates in USD
Average growth rate | +58.18% |
Average growth rate | +592.25% |
More ▼